Please login to the form below

Not currently logged in
Email:
Password:

Leem

This page shows the latest Leem news and features for those working in and with pharma, biotech and healthcare.

GSK replaces China head as bribery probe rolls on

GSK replaces China head as bribery probe rolls on

previously worked in China and currently serves as president of the French industry trade body LEEM, although he will leave this post next month.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    Indeed, Les Entreprises du Médicament (LEEM; Pharmaceutical Companies), the association that represents French drug manufacturers, reports that the pharmaceutical industry contributed 5b of savings in the last three years - half of

  • Country report: The healthcare market in France Country report: The healthcare market in France

    According to the industry association, Les Entreprises du Médicament (LEEM), the market lost momentum in 2010, achieving growth of just 0.7 per cent over 2009, or 27.3bn in revenue. ... LEEM described the budget cuts and added levies on the industry as

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics